zoledronic acid teva pharma
teva b.v. - zoledronic acid - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - drugs for treatment of bone diseases - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. treatment of paget’s disease of the bone in adults.,
budesonide teva pharma 0.25 mg/2ml nebuliser suspension
teva pharma b.v. - budesonide - nebuliser suspension - 0.25 mg/2ml - glucocorticoids
budesonide teva pharma 1 mg/2 ml nebuliser suspension
teva pharma b.v. - budesonide - nebuliser suspension - 1 mg/2ml - glucocorticoids; budesonide
budesonide teva pharma 0.5 mg/2 ml nebuliser suspension
teva pharma b.v. - budesonide - nebuliser suspension - 0.5 mg/2ml - glucocorticoids; budesonide
candesartan teva pharma 32 milligram tablets
teva pharma b.v. - candesartan cilexetil - tablets - 32 milligram
candesartan teva pharma 16 milligram tablets
teva pharma b.v. - candesartan cilexetil - tablets - 16 milligram
candesartan teva pharma 4 milligram tablets
teva pharma b.v. - candesartan cilexetil - tablets - 4 milligram
candesartan teva pharma 8 milligram tablets
teva pharma b.v. - candesartan cilexetil - tablets - 8 milligram
ramipril teva pharma 1.25mg tablets
teva pharma b.v. - ramipril - tablet - 1.25 milligram(s) - ace inhibitors, plain; ramipril
imatinib teva pharma 100 mg film-coated tablets
teva pharma b.v. (utrecht) swensweg 5, 2031 ga haarlem, netherlands - imatinib - film-coated tablet - imatinib 100 mg - antineoplastic agents